Knowledge Distillery

COVID‐19 related acute neurological phenotypes are being increasingly recognized, with neurological complications reported in over 30% of hospitalized…

Mounting evidence supports an association between Guillain‐Barré syndrome spectrum (GBSs) and SARS‐CoV‐2 infection.

The objective of this retrospective cohort study was to quantify rates of organ specific dysfunction in individuals with COVID-19 after discharge from…

The objective of this living systematic review and network meta-analysis was to compare the effects of treatments for COVID-19.

COVID-19 is an ongoing infectious disease caused by the RNA SARS-CoV-2 virus.

In this study, the authors aimed to determine the rates of cerebral venous sinus thrombosis (CVT) and its impact on outcomes in patients with…

This study investigated the association between COVID-related myalgia experienced by patients at hospital admission and the presence of post-COVID…

The objective of this study was to assess patients Quality of life (QoL) and the burden of their caregivers during COVID-19 pandemic and specifically…

Disease-modifying therapies (DMT) for relapsing-remitting MS (RRMS) act on the immune system, suggesting a need for caution during the…

The main objective of this study was to analyse neurological symptoms during a COVID-19 infection and determine the pattern of symptoms by comparing…

Since vaccination against COVID-19 became available, risks related to vaccinating patients with MS need to be carefully assessed.

The objective of this study was to examine the outcomes of adult patients with spontaneous intracranial and subarachnoid hemorrhage diagnosed with…